Abstract
Recent advances in retinal imaging pathophysiology have shown a new function for biomarkers in Alzheimer’s disease diagnosis and prognosis. The significant improvements in Optical coherence tomography (OCT) retinal imaging have led to significant clinical translation, particularly in Alzheimer’s disease detection. This systematic review will provide a comprehensive overview of retinal imaging in clinical applications, with a special focus on biomarker analysis for use in Alzheimer’s disease detection. Articles on OCT retinal imaging in Alzheimer’s disease diagnosis were identified in PubMed, Google Scholar, IEEE Xplore, and Research Gate databases until March 2021. Those studies using simultaneous retinal imaging acquisition were chosen, while those using sequential techniques were rejected. “Alzheimer’s disease” and “Dementia” were searched alone and in combination with “OCT” and “retinal imaging”. Approximately 1000 publications were searched, and after deleting duplicate articles, 145 relevant studies focused on the diagnosis of Alzheimer’s disease utilizing retinal imaging were chosen for study. OCT has recently been demonstrated to be a valuable technique in clinical practice as according to this survey, 57% of the researchers employed optical coherence tomography, 19% used ocular fundus imaging, 13% used scanning laser ophthalmoscopy, and 11% have used multimodal imaging to diagnose Alzheimer disease. Retinal imaging has become an important diagnostic technique for Alzheimer’s disease. Given the scarcity of available literature, it is clear that future prospective trials involving larger and more homogeneous groups are necessary, and the work can be expanded by evaluating its significance utilizing a machine-learning platform rather than simply using statistical methodologies.
Similar content being viewed by others
Data availability
No datasets were generated or analyzed during the current study.
Abbreviations
- AD:
-
Alzheimer’s Disease
- CNS:
-
Central Nervous System
- RNFL:
-
Retinal Nerve Fibre Layer
- OCT:
-
Optical Coherence Tomography
- SLO:
-
Scanning Laser Ophthalmoscopy
- SD-OCT:
-
Spectral Domain Optical Coherence Tomography
- TD-OCT:
-
Time Domain Optical Coherence Tomography
- SS-OCT:
-
Swept Spectral Optical Coherence Tomography
- CSLO:
-
Confocal Scanning Laser Ophthalmoscopy
- UWF:
-
Ultra-Widefield
- ONH:
-
Optic Nerve Head
- MCI:
-
Mild Cognitive Impairment
- FAI:
-
Fluorescein Angiographic Imaging
- FAF:
-
Fundus Auto-fluorescence
- GC-IPL:
-
ganglion cell-inner plexiform layer
- PERG:
-
Pattern Electroretinogram
- LL:
-
Low Luminance
- LSF:
-
Low spatial frequency
- NIRS:
-
Near-infrared spectroscopy
- NDD:
-
Neurodegenerative diseases
References
Almeida AL, Pires LA, Figueiredo EA, Costa-Cunha LV, Zacharias LC, Preti RC, Monteiro ML, Cunha LP (2019) Correlation between cognitive impairment and retinal neural loss assessed by swept-source optical coherence tomography in patients with mild cognitive impairment. Alzheimer's Dement: Diagnosis, Assess Dis Monit 11:659–669
Alzheimer's Association (2012) 2012 Alzheimer’s disease facts and figures. Alzheimers Dement 8(2):131–168
Anastasakis A, Genead MA, Mcanany JJ, Fishman GA (2012) Evaluation of retinal nerve Fiber layer thickness in retinitis Pigmentosa patients using spectral-domain OCT. Retina (Philadelphia, Pa) 32(2):358
Anders W and Martin P (2010) Alzheimer’s Disease International World Alzheimer Report 2010. https://www.alzint.org/u/WorldAlzheimerReport2010.pdf. Accessed 13 September 2021
Ann JK, Sreedhar A, Tomy RM, Mathew DA (2018) Optical coherence tomography in neuro ophthalmology. Kerala J Ophthalmol 30(2):94
Asanad S, Ross-Cisneros FN, Nassisi M, Barron E, Karanjia R, Sadun AA (2019) The retina in Alzheimer's disease: histomorphometric analysis of an ophthalmologic biomarker. Invest Ophthalmol Vis Sci 60(5):1491–1500
Asanad S, Felix CM, Fantini M, Harrington MG, Sadun AA, Karanjia R (2021) Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature. Sci Rep 11(1):1–9
Ascaso FJ, Cruz N, Modrego PJ, Lopez-Anton R, Santabarbara J, Pascual LF, Lobo A, Cristobal JA (2014) Retinal alterations in mild cognitive impairment and Alzheimer’s disease: an optical coherence tomography study. J Neurol 261(8):1522–1530
Ali Mohamed Ather, Klyne MA (1985) Vision in Vertebrates. https://en.wikipedia.org/wiki/Eye. Accessed 09 January 2022
Australian Government (2021) Dementia in Australia 2021 report. https://www.health.gov.au/news/announcements/dementia-in-australia-2021-report-released. Accessed 07 January 2022
Baker ML, Marino Larsen EK, Kuller LH, Klein R, Klein BE, Siscovick DS, Bernick C, Manolio TA, Wong TY (2007) Retinal microvascular signs, cognitive function, and dementia in older persons: the cardiovascular health study. Stroke 38(7):2041–2047
Baran U, Wang RK (2016) Review of optical coherence tomography based angiography in neuroscience. Neurophotonics 3(1):010902
Bateman R (2015) Alzheimer's disease and other dementias: advances in 2014. Lancet Neurol 14(1):4–6
Bayhan HA, Aslan Bayhan S, Celikbilek A, Tanık N, Gurdal C (2015) Evaluation of the chorioretinal thickness changes in Alzheimer's disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol 43(2):145–151
Bennett TJ (2014) Scanning Laser Ophthalmoscopy. Ophthalmic Photographers' Society. https://www.opsweb.org/page/SLO. Accessed 08 January 2022
Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL (2007) Retinal abnormalities in early Alzheimer’s disease. Invest Ophthalmol Vis Sci 48(5):2285–2289
Berman T, Bayati A (2018) What are Neurodegenerative Diseases and How Do They Affect the Brain?. Front Young Minds 6
Blanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 17(3):377–384
Bowd C, Weinreb RN, Williams JM, Zangwill LM (2000) The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol 118(1):22–26
Bridge H (2016) Effects of cortical damage on binocular depth perception. Philos Trans R Soc B: Biol Sci 371(1697):20150254
Britannica E (1987) Sensory reception: human vision: structure and function of the human eye. Encycl Brittanica 27:179
Bulut M, Kurtulus F, Gozkaya O, Erol MK, Cengiz A, Akıdan M, Yaman A (2018) Evaluation of optical coherence tomography angiographic findings in Alzheimer’s type dementia. Br J Ophthalmol 102(2):233–237
Cabrera DeBuc D, Gaca-Wysocka M, Grzybowski A, Kanclerz P (2019) Identification of retinal biomarkers in Alzheimer’s disease using optical coherence tomography: recent insights, challenges, and opportunities. J Clin Med 8(7):996
Chan VT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, Wong TY, Chen C, Ikram MK, Whitson HE, Lad EM (2019) Spectral-domain OCT measurements in Alzheimer’s disease: a systematic review and meta-analysis. Ophthalmology 126(4):497–510
Cheung CY, Ikram MK, Sabanayagam C, Wong TY (2012) Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension 60(5):1094–1103
Cheung CY, Ong YT, Hilal S, Ikram MK, Low S, Ong YL, Venketasubramanian N, Yap P, Seow D, Chen CL, Wong TY (2015) Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 45(1):45–56
Choi SH, Park SJ, Kim NR (2016) Macular ganglion cell-inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and Alzheimers disease. PLoS One 11(9):e0162202
Colligris P, Perez de Lara MJ, Colligris B, Pintor J (2018) Ocular manifestations of Alzheimer’s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer’s disease. J Ophthalmol 2018:8538573
Coppola G, Di Renzo A, Ziccardi L, Martelli F, Fadda A, Manni G, Barboni P, Pierelli F, Sadun AA, Parisi V (2015) Optical coherence tomography in Alzheimer’s disease: a meta-analysis. PLoS One 10(8):e0134750
Cormack FK, Tovee M, Ballard C (2000) Contrast sensitivity and visual acuity in patients with Alzheimer's disease. Int J Geriatr Psychiatry 15(7):614–620
Crawford TJ (2015) The disengagement of visual attention in Alzheimer's disease: a longitudinal eye-tracking study. Front Aging Neurosci 7:118
Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS (1991) Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 29(1):41–52
Cronin-Golomb A, Sugiura R, Corkin S, Growdon JH (1993) Incomplete achromatopsia in Alzheimer's disease. Neurobiol Aging 14(5):471–477
Cronin-Golomb A, Corkin S, Growdon JH (1995) Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optom Vis Sci: Off Publ Am Acad Optom 72(3):168–176
Csincsik L, MacGillivray TJ, Flynn E, Pellegrini E, Papanastasiou G, Barzegar-Befroei N, Csutak A, Bird AC, Ritchie CW, Peto T, Lengyel I (2018) Peripheral retinal imaging biomarkers for Alzheimer’s disease: a pilot study. Ophthalmic Res 59(4):182–192
Cunha LP, Lopes LC, Costa-Cunha LV, Costa CF, Pires LA, Almeida AL, Monteiro ML (2016) Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimerʼs disease. PLoS One 11(4):e0153830
Cunha JP, Proenca R, Dias-Santos A, Melancia D, Almeida R, Aguas H, Santos BO, Alves M, Ferreira J, Papoila AL, Louro C (2017) Choroidal thinning: Alzheimer's disease and aging. Alzheimer's Dement: Diagnosis, Assess Dis Monit 8:11–17
Danesh-Meyer HV, Birch H, Ku JF, Carroll S, Gamble G (2006) Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67(10):1852–1854
de Leon BK, Zetterberg MJH (2006) Alzheimer’s disease. Lancet 29:368
den Haan J, Janssen SF, van de Kreeke JA, Scheltens P, Verbraak FD, Bouwman FH (2018) Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer's disease and controls. Alzheimer's Dement: Diagnosis, Assess Dis Monit 10:49–55
den Haan J, Csinscik L, Parker T, Paterson RW, Slattery CF, Foulkes A, Bouwman FH, Verbraak FD, Scheltens P, Peto T, Lengyel I (2019a) Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer’s disease. Alzheimers Res Ther 11(1):1–9
den Haan J, van de Kreeke JA, van Berckel BN, Barkhof F, Teunissen CE, Scheltens P, Verbraak FD, Bouwman FH (2019b) Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease? Alzheimer's Dement: Diagnosis, Assess Dis Monit 11:383–391
Devi SM, Mahalaxmi I, Aswathy NP, Dhivya V, Balachandar V (2020) Does retina play a role in Parkinson's disease? Acta Neurol Belg 120(2):257–265
Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M (2017) Optical coherence tomography in Alzheimer’s disease and other neurodegenerative diseases. Front Neurol 8:701
Ehler M, Dobrosotskaya J, Cunningham D, Wong WT, Chew EY, Czaja W, Bonner RF (2015) Modeling photo-bleaching kinetics to create high resolution maps of rod rhodopsin in the human retina. PLoS One 10(7):e0131881
Eraslan M, Cerman E, Cekic O, Balci S, Dericioglu V, Sahin O, Suer D, Chabou B, Elmaci EN (2015) Neurodegeneration in ocular and central nervous systems: optical coherence tomography study in normal-tension glaucoma and Alzheimer disease. Turk J Med Sci 45(5):1106–1114
Esmaeelpour M, Povazay B, Hermann B, Hofer B, Kajic V, Kapoor K, Sheen NJ, North RV, Drexler W (2010) Three-dimensional 1060-nm OCT: choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients. Invest Ophthalmol Vis Sci 51(10):5260–5266
European Medicines Agency (2011) World Alzheimer's Day: 21 September 2011. https://www.ema.europa.eu/en/news/world-alzheimers-day-21-september-2011. Accessed 08 January 2022
Feigin VL, Vos T (2019) Global burden of neurological disorders: from global burden of disease estimates to actions. Neuroepidemiology 52(1–2):1–3
Ferrari L, Huang SC, Magnani G, Ambrosi A, Comi G, Leocani L (2017) Optical coherence tomography reveals retinal neuroaxonal thinning in frontotemporal dementia as in Alzheimer’s disease. J Alzheimers Dis 56(3):1101–1107
Finke M, Kantelhardt S, Schlaefer A, Bruder R, Lankenau E, Giese A, Schweikard (2012) Automatic scanning of large tissue areas in neurosurgery using optical coherence tomography. Int J Medl Robot Comp Assisted Surg 8(3):327–336
Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675
Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA (2013) Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease. Transl Psychiatry 3(2):e233–e233
Gao L, Liu Y, Li X, Bai Q, Liu P (2015) Abnormal retinal nerve fiber layer thickness and macula lutea in patients with mild cognitive impairment and Alzheimer's disease. Arch Gerontol Geriatr 60(1):162–167
Garcia Martin ES, Rojas Lopez B, Ramirez Sebastian AI, Hoz Montanana RD, Salazar Corral JJ, Yubero Pancorbo R, Gil P, Trivino Casado A, Ramirez Sebastian JM (2014) Macular thickness as a potential biomarker of mild Alzheimer's disease. Ophthalmology 121(5):1149–1151
Garcia T, Bonnay G, Tourbah A, Arndt C (2013) Optical coherence tomography in neuro-ophthalmology. Optical Coherence Tomography :77–100
Garcia-Martin E, Bambo MP, Marques ML, Satue M, Otin S, Larrosa JM, Polo V, Pablo LE (2016) Ganglion cell layer measurements correlate with disease severity in patients with a lzheimer's disease. Acta Ophthalmol 94(6):e454–e459
Gerloff O (1891) Uber die photographie des augenhintergrundes. Klin Monatsblätter Augenheilkunde 29:397–403
Giardini ME, Zippo AG, Valente M, Krstajic N, Biella GE (2016) Electrophysiological and anatomical correlates of spinal cord optical coherence tomography. PLoS One 11(4):e0152539
Gilmore GC, Levy JA (1991) Spatial contrast sensitivity in Alzheimer's disease: a comparison of two methods. Optom Vis Sci: Off Publ Am Acad Optom 68(10):790–794
Gilmore GC, Wenk HE, Naylor LA, Koss E (1994) Motion perception and Alzheimer's disease. J Gerontol 49(2):P52–P57
Gilmore GC, Groth KE, Thomas CW (2005) Stimulus contrast and word reading speed in Alzheimer's disease. Exp Aging Res 31(1):15–33
Gimenez Castejon D, Dudekova M, Gomez Gallego M, Lajara Blesa J (2016) Macular thickness in subjective memory complaints and mild cognitive impairment: a non-invasive biomarker. Neuro-Ophthalmology 40(1):16–22
Google trends (2021) Alzheimer disease. https://trends.google.com/trends/explore?q=%2Fm%2F0dcsx&geo=IN. Accessed 07 January 2022
Greenberg BM, Frohman E (2010) Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord 3(3):153–160
Gullstrand A (1910) New methods of reflexless ophthalmoscopy. Rep German Ophthalmol Soc 36(8):326
Gunes A, Demirci S, Tok L, Tok O, Demirci S (2015) Evaluation of retinal nerve fiber layer thickness in Alzheimer disease usingspectral-domain optical coherence tomography. Turk J Med Sci 45(5):1094–1097
Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M (2016) Ocular indicators of Alzheimer’s: exploring disease in the retina. Acta Neuropathol 132(6):767–787
Hedges TR III, Galves RP, Speigelman D, Barbas NR, Peli E, Yardley CJ (1996) Retinal nerve fiber layer abnormalities in Alzheimer's disease. Acta Ophthalmol Scand 74(3):271–275
Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA (1991) Optical coherence tomography. Science 254(5035):1178–1181
Iseri PK, Altinas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26(1):18–24
Ishikawa H, Stein DM, Wollstein G, Beaton S, Fujimoto JG, Schuman JS (2005) Macular segmentation with optical coherence tomography. Invest Ophthalmol Vis Sci 46(6):2012–2017
Islam MS (2013) Optical coherence tomography for structural neuroimaging and non-contact recording of functionally stimulated neural activity. University of California, Riverside
Janez-Escalada L, Janez-García L, Salobrar-Garcia E, Santos-Mayo A, de Hoz R, Yubero R, Gil P, Ramírez JM (2019) Spatial analysis of thickness changes in ten retinal layers of Alzheimer’s disease patients based on optical coherence tomography. Sci Rep 9(1):1–4
Javaid FZ, Brenton J, Guo L, Cordeiro MF (2016) Visual and ocular manifestations of Alzheimer’s disease and their use as biomarkers for diagnosis and progression. Front Neurol 7:55
Javaid SF, Giebel C, Khan MA, Hashim MJ (2021) Epidemiology of Alzheimer’s disease and other dementias: rising global burden and forecasted trends. F1000Research 10(425):425
Jiang H, Wei Y, Shi Y, Wright CB, Sun X, Gregori G, Zheng F, Vanner EA, Lam BL, Rundek T, Wang J (2018) Altered macular microvasculature in mild cognitive impairment and Alzheimer disease. J Neuro-Ophthalmol:Off J North Am Neuro-Ophthalmol Soc 38(3):292
Kang BH, Kim JI (2013) Decreased retinal thickness in patients with Alzheimer's disease. J Korean Neurol Assoc 31(3):173–177
Kavcic V, Vaughn W, Duffy CJ (2011) Distinct visual motion processing impairments in aging and Alzheimer’s disease. Vis Res 51(3):386–395
Kernt M, Hadi I, Pinter F, Seidensticker F, Hirneiss C, Haritoglou C, Kampik A, Ulbig MW, Neubauer AS (2012) Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care 35(12):2459–2463
Kesler A, Vakhapova V, Korczyn AD, Naftaliev E (2011) Neudorfer M. retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 113(7):523–526
Kim JI, Kang BH (2019) Decreased retinal thickness in patients with Alzheimer’s disease is correlated with disease severity. PLoS One 14(11):e0224180
Kirbas S, Turkyilmaz K, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 33(1):62–65
Klaver CC, Ott A, Hofman A, Assink JJ, Breteler MM, de Jong PT (1999) Is age-related maculopathy associated with Alzheimer's disease?: the Rotterdam study. Am J Epidemiol 150(9):963–968
Klein BE, Moss SE, Klein R, Lee KE, Cruickshanks KJ (2003) Associations of visual function with physical outcomes and limitations 5 years later in an older population: the beaver dam eye study. Ophthalmology 110(4):644–650
Knoll B, Simonett J, Volpe NJ, Farsiu S, Ward M, Rademaker A, Weintraub S, Fawzi AA (2016) Retinal nerve fiber layer thickness in amnestic mild cognitive impairment: case-control study and meta-analysis. Alzheimer's Dement: Diagnosis, Assess Dis Monit 4:85–93
Kolb H (2003) How the retina works: much of the construction of an image takes place in the retina itself through the use of specialized neural circuits. Am Sci 91(1):28–35
Kollner H (1912) The disorders of the color sense, their clinical significance and their diagnosis. S. Karger
Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, Kile SJ, Blanco A, Fuchs DT, Ashfaq A, Frautschy S (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease. JCI insight 2(16):e93621
Kromer R, Serbecic N, Hausner L, Aboul-Enein F, Froelich L, Beutelspacher S (2014) Detection of retinal nerve fiber layer defects in Alzheimer’s disease using SD-OCT. Front Psychiatry 5:2
Kurna SA, Akar G, Altun A, Agirman Y, Gozke E, Sengor T (2014) Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer’s disease compared to glaucoma and control. Int Ophthalmol 34(6):1203–1211
Kwon JY, Yang JH, Han JS (2017) Analysis of the retinal nerve fiber layer thickness in Alzheimer disease and mild cognitive impairment. Korean J Ophthalmol 31(6):548–556
La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, Sambati L, Pan BX, Tozer KR, Barboni P, Provini F (2016) Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol 79(1):90–109
Lad EM, Mukherjee D, Stinnett SS, Cousins SW, Potter GG, Burke JR, Farsiu S, Whitson HE (2018) Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer’s disease. PLoS One 13(2):e0192646
Lakshminarayanan V, Lagrave J, Louise Kean M, Dick M, Shankle R (1996) Vision in dementia: contrast effects. Neurol Res 18(1):9–15
Lamb TD, Collin SP, Pugh EN (2007) Evolution of the vertebrate eye: opsins, photoreceptors, retina and eye cup. Nat Rev Neurosci 8(12):960–976
Lee AG, Martin CO (2004) Neuro-ophthalmic findings in the visual variant of Alzheimer's disease. Ophthalmology 111(2):376–380
Lee CN, Ko D, Suh YW, Park KW (2015) Cognitive functions and stereopsis in patients with Parkinson’s disease and Alzheimer’s disease using 3-dimensional television: a case controlled trial. PLoS One 10(3):e0123229
Lemmens S, Devulder A, Van Keer K, Bierkens J, De Boever P, Stalmans I (2020) Systematic review on fractal dimension of the retinal vasculature in neurodegeneration and stroke: assessment of a potential biomarker. Front Neurosci 14:16
Leung CK, Cheung CY, Weinreb RN, Qiu Q, Liu S, Li H, Xu G, Fan N, Huang L, Pang CP, Lam DS (2009) Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a variability and diagnostic performance study. Ophthalmology 116(7):1257–1263
Li B, Wang H, Fu B, Wang R, Sakadzic S, Boas DA (2017) Impact of temporal resolution on estimating capillary RBC-flux with optical coherence tomography. J Biomed Opt 22(1):016014
Li Y, Xia X, Paulus YM (2018) Advances in retinal optical imaging. Photonics 5(2):9
Li M, Li R, Lyu JH, Chen JH, Wang W, Gao ML, Li WJ, De J, Mu HY, Pan WG, Mao PX (2021) Relationship Between Alzheimer’s Disease and Retinal Choroidal Thickness: A Cross-Sectional Study. J Alzheimer's Dis 1–3
Liao H, Zhu Z, Peng Y (2018) Potential utility of retinal imaging for Alzheimer’s disease: a review. Front Aging Neurosci 10:188
Linden DE (2012) The challenges and promise of neuroimaging in psychiatry. Neuron 73(1):8–22
Liu D, Zhang L, Li Z, Zhang X, Wu Y, Yang H, Min B, Zhang X, Ma D, Lu Y (2015a) Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer’s disease. BMC Neurol 15(1):1–5
Liu T, Liu X, Wen R, Lam BL, Jiao S (2015b) In vivo imaging rhodopsin distribution in the photoreceptors with nano-second pulsed scanning laser ophthalmoscopy. Quant Imaging Med Surg 5(1):63
Liu S, Ong YT, Hilal S, Loke YM, Wong TY, Chen CL, Cheung CY, Zhou J (2016) The association between retinal neuronal layer and brain structure is disrupted in patients with cognitive impairment and Alzheimer’s disease. J Alzheimers Dis 54(2):585–595
Liu YL, Hsieh YT, Chen TF, Chiou JM, Tsai MK, Chen JH, Chen YC (2019) Retinal ganglion cell–inner plexiform layer thickness is nonlinearly associated with cognitive impairment in the community-dwelling elderly. Alzheimer's Dement: Diagnosis, Assess Dis Monit 11:19–27
London A, Benhar I, Schwartz M (2013) The retina as a window to the brain—from eye research to CNS disorders. Nat Rev Neurol 9(1):44–53
Lopez-Cuenca I, de Hoz R, Salobrar-García E, Elvira-Hurtado L, Rojas P, Fernandez-Albarral JA, Barabash A, Salazar JJ, Ramírez AI, Ramirez JM (2020) Macular thickness decrease in asymptomatic subjects at high genetic risk of developing Alzheimer’s disease: an OCT study. J Clin Med 9(6):1728
Lopez-Cuenca I, de Hoz R, Alcantara-Rey C, Salobrar-Garcia E, Elvira-Hurtado L, Fernandez-Albarral JA, Barabash A, Ramirez-Torano F, de Frutos-Lucas J, Salazar JJ, Ramirez AI (2021) Foveal avascular zone and choroidal thickness are decreased in subjects with hard Drusen and without high genetic risk of developing Alzheimer’s disease. Biomedicines 9(6):638
Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, Ma D (2010) Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci Lett 480(1):69–72
MacGillivray TJ, Trucco E, Cameron JR, Dhillon B, Houston JG, Van Beek EJ (2014) Retinal imaging as a source of biomarkers for diagnosis, characterization and prognosis of chronic illness or long-term conditions. Br J Radiol 87(1040):20130832
Mapstone M, Dickerson K, Duffy CJ (2008) Distinct mechanisms of impairment in cognitive ageing and Alzheimer's disease. Brain 131(6):1618–1629
Marquie M, Valero S, Castilla-Marti M, Martinez J, Rodriguez-Gomez O, Sanabria A, Tartari JP, Monte-Rubio GC, Sotolongo-Grau O, Alegret M, Perez-Cordon A (2020) Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundacio ACE healthy brain initiative. Alzheimers Res Ther 12(1):1–4
Marziani E, Pomati S, Ramolfo P, Cigada M, Giani A, Mariani C, Staurenghi G (2013) Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 54(9):5953–5958
Max Roser and Hannah Ritchie (2016) Burden of Disease. https://ourworldindata.org/burden-of-disease#citation. Accessed 13 September 2021
Mayo clinic (2021) Alzheimer’s disease. https://www.mayoclinic.org/diseases-c85onditions/alzheimers-disease/symptoms-causes/syc-20350447. Accessed 08 January 2022
Minakaran N, de Carvalho ER, Petzold A, Wong SH (2021) Optical coherence tomography (OCT) in neuro-ophthalmology. Eye 35(1):17–32
Mittenberg W, Choi EJ, Apple CC (2000) Stereoscopic visual impairment in vascular dementia. Arch Clin Neuropsychol 15(7):561–569
Moschos M, Markopoulos I, Chatziralli I, Rouvas AG, Papageorgiou S, Ladas I, Vassilopoulos D (2012) Structural and functional impairment of the retina and optic nerve in Alzheimer's disease. Curr Alzheimer Res 9(7):782–788
Mutlu U, Bonnemaijer PW, Ikram MA, Colijn JM, Cremers LG, Buitendijk GH, Vingerling JR, Niessen WJ, Vernooij MW, Klaver CC, Ikram MK (2017) Retinal neurodegeneration and brain MRI markers: the Rotterdam study. Neurobiol Aging 60:183–191
Neargarder SA, Stone ER, Cronin-Golomb A, Oross S III (2003) The impact of acuity on performance of four clinical measures of contrast sensitivity in Alzheimer's disease. J Gerontol Ser B Psychol Sci Soc Sci 58(1):P54–P62
Nguyen Phuc Thu T, Hernandez AI, Costet N, Patural H, Pichot V, Carrault G, Beuchee A (2019) Improving methodology in heart rate variability analysis for the premature infants: impact of the time length. PLoS One 14(8):e0220692
NHS (2021) Treatment Alzheimer’s disease. https://www.nhs.uk/conditions/alzheimers-disease/treatment/. Accessed 09 January 2022
Novotny HR, Alvis DL (1961) A method of photographing fluorescence in circulating blood in the human retina. Circulation 24(1):82–86
O’Bryhim BE, Apte RS, Kung N, Coble D, Van Stavern GP (2018) Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol 136(11):1242–1248
Oktem EO, Derle E, Kibaroglu S, Oktem C, Akkoyun I, Can U (2015) The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci 36(7):1141–1146
Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J (2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 420(2):97–99
Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 112(10):1860–1867
Passafiume D, Di Giacomo D, Giubilei F (2000) Reading latency of words and nonwords in Alzheimer's patients. Cortex 36(2):293–298
Pelli DG, Robson JG (1988) The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci 2(3):187–199
Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Ehlers JP, Leverenz JB (2016) Retinal nerve fiber layer thinning in Alzheimer’s disease: a case–control study in comparison to normal aging, Parkinson’s disease, and non-Alzheimer’s dementia. Am J Alzheimers Dis Other Dement 31(5):430–436
Polo V, Garcia-Martin E, Bambo MP, Pinilla J, Larrosa JM, Satue M, Otin S, Pablo LE (2014) Reliability and validity of cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer’s disease. Eye 28(6):680–690
Polo V, Rodrigo MJ, Garcia-Martin E, Otin S, Larrosa JM, Fuertes MI, Bambo MP, Pablo LE, Satue M (2017) Visual dysfunction and its correlation with retinal changes in patients with Alzheimer's disease. Eye 31(7):1034–1041
Poroy C, Yucel AA (2018) Optical coherence tomography: is really a new biomarker for alzheimer's disease? Ann Indian Acad Neurol 21(2):119
Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology 102(2):217–229
Qiu C, Cotch MF, Sigurdsson S, Jonsson PV, Jonsdottir MK, Sveinbjrnsdottir S, Eiriksdottir G, Klein R, Harris TB, Van Buchem MA, Gudnason V (2010) Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik study. Neurology 75(24):2221–2228
Querques G, Borrelli E, Sacconi R, De Vitis L, Leocani L, Santangelo R, Magnani G, Comi G, Bandello F (2019) Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment. Sci Rep 9(1):1–10
Risacher SL, WuDunn D, Pepin SM, MaGee TR, McDonald BC, Flashman LA, Wishart HA, Pixley HS, Rabin LA, Paré N, Englert JJ (2013) Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints. Neurobiol Aging 34(4):1133–1144
Rizzo M, Nawrot M (1998) Perception of movement and shape in Alzheimer's disease. Brain J Neurol 121(12):2259–2270
Rizzo M, Anderson SW, Dawson J, Nawrot M (2000) Vision and cognition in Alzheimer’s disease. Neuropsychologia 38(8):1157–1169
Robbins CB, Grewal DS, Thompson AC, Powers JH, Soundararajan S, Koo HY, Yoon SP, Polascik BW, Liu A, Agrawal R, Fekrat S (2021) Choroidal structural analysis in Alzheimer disease, mild cognitive impairment, and cognitively healthy controls. Am J Ophthalmol 223:359–367
Rolle T, Dallorto L, Bonetti B (2016) Retinal and macular ganglion cell count estimated with optical coherence tomography RTVUE-100 as a candidate biomarker for glaucoma. Invest Ophthalmol Vis Sci 57(13):5772–5779
RSIP Vision (2021) Degenerative Diseases Detection in the Eye. https://rsipvision.com/degenerative-diseases-detection-in-the-eye/. Accessed 08 January 2022
Saine PJ, Patrick J, Tyler ME (2013) Fundus photography overview. Ophthalmic Photographers' Society. https://www.opsweb.org/page/fundusphotography. Accessed 08 January 2022
Salamone G, Di Lorenzo C, Mosti S, Lupo F, Cravello L, Palmer K, Musicco M, Caltagirone C (2009) Color discrimination performance in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 27(6):501–507
Salobrar-Garcia E, Hoyas I, Leal M, de Hoz R, Rojas B, Ramirez AI, Salazar JJ, Yubero R, Gil P, Trivino A, Ramirez JM (2015) Analysis of retinal peripapillary segmentation in early Alzheimer’s disease patients. BioMed Res Int 2015
Salobrar-Garcia E, de Hoz R, Raminez AI, Lopez-Cuenca I, Rojas P, Vazirani R, Amarante C, Yubero R, Gil P, Pinazo-Duran MD, Salazar JJ (2019) Changes in visual function and retinal structure in the progression of Alzheimer's disease. PLoS One 14(8):e0220535
Sanchez D, Castilla-Marti M, Rodriguez-Gomez O, Valero S, Piferrer A, Martínez G, Martínez J, Serra J, Moreno-Grau S, Hernandez-Olasagarre B, De Rojas I (2018) Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease. Sci Rep 8(1):1–10
Sandeep CS, Kumar AS (2015) A review on the early diagnosis of Alzheimer's disease (AD) through different tests, techniques and databases. AMSE J Model C 76(1):1–22
Sandeep CS, Kumar AS (2017) Early prediction of Alzheimer’s disease by examining changes in eye parameters. J Anal Pharm Res 5(6):00159
Sandeep CS, Kumar S, Mahadevan K, Manoj P (2019) Early prediction of Alzheimer’s disease using OCT imaging technique. J Alzheimer's Res Ther 1(1):15
Santos CY, Johnson LN, Sinoff SE, Festa EK, Heindel WC, Snyder PJ (2018) Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease. Alzheimer's Dement: Diagnosis, Assess Dis Monit 10:196–209
Siesler HW, Ozaki Y, Kawata S, Heise HM, editors (2008) Near-infrared spectroscopy: principles, instruments, applications. John Wiley & Sons
Termsarasab P, Thammongkolchai T, Rucker JC, Frucht SJ (2015) The diagnostic value of saccades in movement disorder patients: a practical guide and review. J Clin Mov Disord 2(1):1–10
Thomson KL, Yeo JM, Waddell B, Cameron JR, Pal S (2015) A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimer's Dement: Diagnosis, Assess Dis Monit 1(2):136–143
Tong Y, Lu W, Yu Y, Shen Y (2020) Application of machine learning in ophthalmic imaging modalities. Eye Vision 7(1):1–5
Trebbastoni A, Marcelli M, Mallone F, D’Antonio F, Imbriano L, Campanelli A, de Lena C, Gharbiya M (2017) Attenuation of choroidal thickness in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 31(2):128–134
Trick GL, Trick LR, Morris P, Wolf M (1995) Visual field loss in senile dementia of the Alzheimer's type. Neurology 45(1):68–74
Tsai CS, Ritch R, Schwartz B, Lee SS, Miller NR, Chi T, Hsieh FY (1991) Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch Ophthalmol 109(2):199–204
Uchida A, Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Leverenz JB, Srivastava SK, Ehlers JP (2018) Outer retinal assessment using spectral-domain optical coherence tomography in patients with Alzheimer's and Parkinson's disease. Invest Ophthalmol Vis Sci 59(7):2768–2777
Valenti DA (2010) Alzheimer's disease and glaucoma: imaging the biomarkers of neurodegenerative disease. Int J Alzheimer’s Dis
Valenti DA (2013) Alzheimer’s disease: screening biomarkers using frequency doubling technology visual field. Int Sch Res Not
Van de Kreeke JA, Nguyen HT, den Haan J, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Collij L, Yaqub M, van Berckel B, Lammertsma AA (2019) Retinal layer thickness in preclinical Alzheimer's disease. Acta Ophthalmol 97(8):798–804
Van De Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, Den Braber A, Ten Kate M, Yaqub M, Van Berckel B, Lammertsma AA, Boomsma DI, Tan SH (2020) Optical coherence tomography angiography in preclinical Alzheimer’s disease. Br J Ophthalmol 104(2):157–161
Van de Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, den Braber A, Ten Kate M, Yaqub M, van Berckel B, Lammertsma AA, Boomsma DI, Tan HS (2021) Longitudinal retinal layer changes in preclinical Alzheimer’s disease. Acta Ophthalmol 99(5):538–544
Vij R, Arora S (2021) Computer Vision with Deep Learning Techniques for Neurodegenerative Diseases Analysis Using Neuroimaging: A Survey. In International Conference on Innovative Computing and Communications 179–189
Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, Aboyans V (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet 390(10100):1211–1259
Webb RH, Hughes GW, Pomerantzeff O (1980) Flying spot TV ophthalmoscope. Appl Opt 19(17):2991–2997
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053
Wu SZ, Masurkar AV, Balcer LJ (2020) Afferent and efferent visual markers of Alzheimer’s disease: a review and update in early stage disease. Front Aging Neurosci 12:293
Wylegala A (2018) Principles of OCTA and applications in clinical neurology. Curr Neurol Neurosci Rep 18(12):1–10
Xu J, Wei W, Song S, Qi X, Wang RK (2016) Scalable wide-field optical coherence tomography-based angiography for in vivo imaging applications. Biomed Opt Express 7(5):1905–1919
Yang J, Liu P, Duan L, Hu Y, Liu J (2019) Deep learning enables extraction of capillary-level angiograms from single OCT volume. arXiv preprint arXiv:1906.07091
Yoon SP, Grewal DS, Thompson AC, Polascik BW, Dunn C, Burke JR, Fekrat S (2019) Retinal microvascular and neurodegenerative changes in Alzheimer’s disease and mild cognitive impairment compared with control participants. Ophthalmol Retina 3(6):489–499
Zabel P, Kaluzny JJ, Zabel K, Kaluzna M, Lamkowski A, Jaworski D, Makowski J, Gebska-Toloczko M, Kucharski R (2021) Quantitative assessment of retinal thickness and vessel density using optical coherence tomography angiography in patients with Alzheimer’s disease and glaucoma. PLoS One 16(3):e0248284
Zafar S, McCormick J, Giancardo L, Saidha S, Abraham A, Channa R (2019) Retinal imaging for neurological diseases: “a window into the brain”. Int Ophthalmol Clin 59(1):137–154
Zhao LH (2020) Alzheimer’s disease facts and figures. Alzheimers Dement 16:391–460
Zhao A, Fang F, Li B, Chen Y, Qiu Y, Wu Y, Xu W, Deng Y (2021) Visual abnormalities associate with Hippocampus in mild cognitive impairment and early Alzheimer's disease. Front Aging Neurosci 12:522
Ziemssen T, Ziemssen F (2013) Perspectives of an innovative ophthalmological technology: optical coherence tomography (OCT)–what should be of interest to the neurologist? Clin Neurol Neurosurg 115:S55–S59
Author information
Authors and Affiliations
Contributions
1 Richa Vij: Conceptualization, Methodology, Writing-Original draft preparation, Visualization, Formal analysis.
2 Sakshi Arora: Supervision, Writing- Reviewing and Editing, Validation.
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vij, R., Arora, S. A systematic survey of advances in retinal imaging modalities for Alzheimer’s disease diagnosis. Metab Brain Dis 37, 2213–2243 (2022). https://doi.org/10.1007/s11011-022-00927-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-00927-4